Lentiviral Vector Integration Profiles Differ in Rodent Postmitotic Tissues-Reference-Cited by-同舟云学术

Lentiviral Vector Integration Profiles Differ in Rodent Postmitotic Tissues

Published:2011-04 Issue:4 Volume:19 Page:703-710
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Bartholomae Cynthia C,Arens Anne,Balaggan Kamaljit S,Yáñez-Muñoz Rafael J,Montini Eugenio,Howe Steven J,Paruzynski Anna,Korn Bernhard,Appelt Jens Uwe,MacNeil Angus,Cesana Daniela,Abel Ulrich,Glimm Hanno,Naldini Luigi,Ali Robin R,Thrasher Adrian J,von Kalle Christof,Schmidt Manfred

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference39 articles.

1. Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery;Zufferey;J Virol,1998

2. Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy;Cartier;Science,2009

3. Hematopoietic stem cell gene transfer in a tumor-prone mouse model uncovers low genotoxicity of lentiviral vector integration;Montini;Nat Biotechnol,2006

4. The genotoxic potential of retroviral vectors is strongly modulated by vector design and integration site selection in a mouse model of HSC gene therapy;Montini;J Clin Invest,2009

5. Insertional transformation of hematopoietic cells by self-inactivating lentiviral and gammaretroviral vectors;Modlich;Mol Ther,2009

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Viral-based animal models in polyglutamine disorders;Brain;2024-01-29

2. Advanced Therapy Medicinal Products: Clinical, Non-clinical, and Quality Considerations;Pharmaceutical Biotechnology;2024

3. Nanomedicine and drug delivery to the retina: current status and implications for gene therapy;Naunyn-Schmiedeberg's Archives of Pharmacology;2022-09-15

4. Novel bicistronic lentiviral vectors correct β-Hexosaminidase deficiency in neural and hematopoietic stem cells and progeny: implications for in vivo and ex vivo gene therapy of GM2 gangliosidosis;Neurobiology of Disease;2020-02

5. Biosafety Studies of a Clinically Applicable Lentiviral Vector for the Gene Therapy of Artemis-SCID;Molecular Therapy - Methods & Clinical Development;2019-12